Nanomaterials Enhance Pyroptosis-Based Tumor Immunotherapy

References

• Shi JJ, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–665. doi:10.1038/nature15514
   PubMed Web of Science ®Google Scholar
• Baker PJ, Boucher D, Bierschenk D, et al. NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5. Eur J Immunol. 2015;45(10):2918–2926. doi:10.1002/eji.201545655
   PubMed Web of Science ®Google Scholar
• Rühl S, Broz P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K+ efflux. Eur J Immunol. 2015;45(10):2927–2936. doi:10.1002/eji.201545772
   PubMed Web of Science ®Google Scholar
• Wang YP, Gao WQ, Shi XY, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99–103. doi:10.1038/nature22393
   PubMed Web of Science ®Google Scholar
• Hou JW, Zhao RC, Xia WY, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020;22(10):1264–1275. doi:10.1038/s41556-020-0575-z
   PubMed Web of Science ®Google Scholar
• Zhou ZW, He HB, Wang K, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368(6494):eaaz7548. doi:10.1126/science.aaz7548
   PubMed Web of Science ®Google Scholar
• Liu YY, Fang YL, Chen XF, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol. 2020;5(43):eaax7969. doi:10.1126/sciimmunol.aax7969
   PubMed Web of Science ®Google Scholar
• Lu L, Zhang Y, Tan X, et al. Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer. Cell Death Discov. 2022;8(1):338. doi:10.1038/s41420-022-01101-6
   PubMed Web of Science ®Google Scholar
• Zhang ZB, Zhang Y, Xia SY, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415–420. doi:10.1038/s41586-020-2071-9
   PubMed Web of Science ®Google Scholar
• Lin J, Sun S, Zhao K, et al. Oncolytic parapoxvirus induces gasdermin E-mediated pyroptosis and activates antitumor immunity. Nat Commun. 2023;14(1):224. doi:10.1038/s41467-023-35917-2
   PubMed Web of Science ®Google Scholar
• Kumar D, Gurrapu S, Wang Y, et al. LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells. Nat Cancer. 2024;5:262–282. doi:10.1038/s43018-023-00695-9
   PubMedGoogle Scholar
• Jin XY, Ma YC, Liu DD, Huang Y. Role of pyroptosis in the pathogenesis and treatment of diseases. Medcomm. 2023;4(3):e249. doi:10.1002/mco2.249
   PubMedGoogle Scholar
• Pan YH, Cai WJ, Huang J, et al. Pyroptosis in development, inflammation and disease. Front Immunol. 2022;13:991044. doi:10.3389/fimmu.2022.991044
   PubMed Web of Science ®Google Scholar
• Koh EH, Yoon JE, Ko MS, et al. Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis. Gut. 2021;70(10):1954–1964. doi:10.1136/gutjnl-2020-322509
   PubMed Web of Science ®Google Scholar
• Tan G, Huang CY, Chen JY, Chen BX, Zhi FC. Gasdermin-E-mediated pyroptosis participates in the pathogenesis of crohn’s disease by promoting intestinal inflammation. Cell Rep. 2021;35(11):109265. doi:10.1016/j.celrep.2021.109265
   PubMed Web of Science ®Google Scholar
• Wei X, Xie F, Zhou XX, et al. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol. 2022;19(9):971–992. doi:10.1038/s41423-022-00905-x
   PubMed Web of Science ®Google Scholar
• Chen L, Sun XQ, Cheng K, et al. Temperature-regulating phase change fiber scaffold toward mild photothermal-chemotherapy. Adv Fiber Mater. 2022;4(6):1669–1684. doi:10.1007/s42765-022-00199-8
   Google Scholar
• Yang J, Xu L, Ding YN, et al. NIR-II-triggered composite nanofibers to simultaneously achieve intracranial hemostasis, killing superbug and residual cancer cells in brain tumor resection surgery. Adv Fiber Mater. 2023;5(1):209–222. doi:10.1007/s42765-022-00210-2
   Google Scholar
• Shi JY, Tian HL, Peng LY, et al. A nanoplatform reshaping intracellular osmolarity and redox homeostasis against colorectal cancer. J Control Release. 2022;352:766–775. doi:10.1016/j.jconrel.2022.11.003
   PubMed Web of Science ®Google Scholar
• Li Y, Lin JY, Wang PY, et al. Tumor microenvironment-responsive yolk-shell NaCl@virus-inspired tetrasulfide- organosilica for ion-interference therapy via osmolarity surge and oxidative stress amplification. ACS Nano. 2022;16(5):7380–7397. doi:10.1021/acsnano.1c09496
   PubMed Web of Science ®Google Scholar
• Wen M, Liu XH, Yu N, et al. Multifunctional hemoporfin-Cu9S8-MnO2 for magnetic resonance imaging-guided catalytically-assisted photothermal-sonodynamic therapies. J Colloid Interface Sci. 2022;626:77–88. doi:10.1016/j.jcis.2022.06.116
   PubMed Web of Science ®Google Scholar
• Wen M, Wang S, Jiang RQ, et al. Tuning the NIR photoabsorption of CuWO4−x nanodots with oxygen vacancies for CT imaging guided photothermal therapy of tumors. Biomater Sci UK. 2019;7(11):4651–4660. doi:10.1039/c9bm00995g
   PubMed Web of Science ®Google Scholar
• Yang YQ, Zhao TJ, Chen QH, et al. Nanomedicine strategies for heating “cold” ovarian cancer (OC): next evolution in immunotherapy of OC. Adv Sci. 2022;9(28):2202797. doi:10.1002/advs.202202797
   Web of Science ®Google Scholar
• Wang WY, Zhang L, Sun ZJ. Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies. Cancer Biol Med. 2022;19(7):948–964. doi:10.20892/j.issn.2095-3941.2022.0049
   PubMed Web of Science ®Google Scholar
• Li LJ, Wang SM, Zhou WH. Balance cell apoptosis and pyroptosis of caspase-3-activating chemotherapy for better antitumor therapy. Cancers (Basel). 2023;15(1):26. doi:10.3390/cancers15010026
   Web of Science ®Google Scholar
• Su LP, Chen YT, Huang C, et al. Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Sci Transl Med. 2023;15(678):eabl7895. doi:10.1126/scitranslmed.abl7895
   PubMed Web of Science ®Google Scholar
• Wan S-C, M-J Y, Yang Q-C, et al. Diselenide-based dual-responsive prodrug as pyroptosis inducer potentiates cancer immunotherapy. Adv Healthc Mater. 2022;12(7):e2202135. doi:10.1002/adhm.202202135
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhang T, Ma XB, et al. Microenvironment-responsive prodrug-induced pyroptosis boosts cancer immunotherapy. Adv Sci. 2021;8(24):2101840. doi:10.1002/advs.202101840
   Web of Science ®Google Scholar
• Wang XT, Wang B, Li F, et al. The c-Src/LIST positive feedback loop sustains tumor progression and chemoresistance. Adv Sci. 2023;10(20):e2300115. doi:10.1002/advs.202300115
   Web of Science ®Google Scholar
• Zhu S-W, Ye M, Ma X, et al. pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer. Acta Biomater. 2022;154:497–509. doi:10.1016/j.actbio.2022.10.051
   PubMed Web of Science ®Google Scholar
• Tan J, Li H, Hu XX, et al. Size-tunable assemblies based on ferrocene-containing DNA polymers for spatially uniform penetration. Chem. 2019;5(7):1775–1792. doi:10.1016/j.chempr.2019.05.024
   Web of Science ®Google Scholar
• Liang MY, Zhang MJ, Qiu W, et al. Stepwise size shrinkage cascade-activated supramolecular prodrug boosts antitumor immunity by eliciting pyroptosis. Adv Sci. 2022;9(26):2203353. doi:10.1002/advs.202203353
   Web of Science ®Google Scholar
• Hogg SJ, Beavis PA, Dawson MA, Johnstone RW. Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov. 2020;19(11):776–800. doi:10.1038/s41573-020-0077-5
   PubMed Web of Science ®Google Scholar
• Morel D, Jeffery D, Aspeslagh S, Almouzni G, Postel-Vinay S. Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise. Nat Rev Clin Oncol. 2020;17(2):91–107. doi:10.1038/s41571-019-0267-4
   PubMed Web of Science ®Google Scholar
• Kim MS, Chang X, Yamashita K, et al. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene. 2008;27(25):3624–3634. doi:10.1038/sj.onc.1211021
   PubMed Web of Science ®Google Scholar
• Mei Z, Chen XY, Chen Y, Su XD, Lv SX, Wei SC. Improved antitumor immunity of chemotherapy in OSCC treatment by gasdermin-E mediated pyroptosis. Apoptosis. 2023;28(3–4):348–361. doi:10.1007/s10495-022-01792-3
   PubMed Web of Science ®Google Scholar
• Fan JX, Deng RH, Wang H, et al. Epigenetics-based tumor cells pyroptosis for enhancing the immunological effect of chemotherapeutic nanocarriers. Nano Lett. 2019;19(11):8049–8058. doi:10.1021/acs.nanolett.9b03245
   PubMed Web of Science ®Google Scholar
• Xie BB, Liu TT, Chen S, et al. Combination of DNA demethylation and chemotherapy to trigger cell pyroptosis for inhalation treatment of lung cancer. Nanoscale. 2021;13(44):18608–18615. doi:10.1039/d1nr05001j
   PubMed Web of Science ®Google Scholar
• Dai EY, Zhu Z, Wahed S, Qu ZX, Storkus WJ, Guo ZS. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol Cancer. 2021;20(1):171. doi:10.1186/s12943-021-01464-x
   PubMed Web of Science ®Google Scholar
• Zhou SY, Shang Q, Ji JB, Luan YX. A nanoplatform to amplify apoptosis-to-pyroptosis immunotherapy via immunomodulation of myeloid-derived suppressor cells. ACS Appl Mater Interfaces. 2021;13(40):47407–47417. doi:10.1021/acsami.1c16154
   PubMed Web of Science ®Google Scholar
• Baumann T, Dunkel A, Schmid C, et al. Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal. Nat Immunol. 2020;21(5):555–566. doi:10.1038/s41590-020-0666-9
   PubMed Web of Science ®Google Scholar
• Chen DR, Gao Y, Xiao Y, et al. Engineered nanogels simultaneously implement HDAC inhibition and chemotherapy to boost antitumor immunity via pyroptosis. Appl Mater Today. 2022;26:101363. doi:10.1016/j.apmt.2022.101363
   Web of Science ®Google Scholar
• Zheng LL, Fan Y, Wang X, et al. Nanoagonist-mediated GSDME-dependent pyroptosis remodels the inflammatory microenvironment for tumor photoimmunotherapy. Adv Funct Mater. 2023;33(6):2200811. doi:10.1002/adfm.202200811
   Web of Science ®Google Scholar
• Guo HL, Huang JS, Tan Y, et al. Nanodrug shows spatiotemporally controlled release of anti-PD-L1 antibody and STING agonist to effectively inhibit tumor progression after radiofrequency ablation. Nano Today. 2022;43:101425. doi:10.1016/j.nantod.2022.101425
   Web of Science ®Google Scholar
• Zhang QQ, Shi DW, Guo MQ, Zhao H, Zhao YB, Yang XL. Radiofrequency-activated pyroptosis of Bi-valent gold nanocluster for cancer immunotherapy. ACS Nano. 2023;17(1):515–529. doi:10.1021/acsnano.2c09242
   PubMed Web of Science ®Google Scholar
• Lopez JS, Banerji U. Combine and conquer: challenges for targeted therapy combinations in early phase trials. Nat Rev Clin Oncol. 2017;14(1):57–66. doi:10.1038/nrclinonc.2016.96
   PubMed Web of Science ®Google Scholar
• Schram AM, Chang MT, Jonsson P, Drilon A. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance. Nat Rev Clin Oncol. 2017;14(12):735–748. doi:10.1038/nrclinonc.2017.127
   PubMed Web of Science ®Google Scholar
• Li Z, Liu Y, Fang X, Shu Z. Nanomaterials enhance the immunomodulatory effect of molecular targeted therapy. Int J Nanomed. 2021;16:1631–1661. doi:10.2147/IJN.S290346
   PubMed Web of Science ®Google Scholar
• Erkes DA, Cai W, Sanchez IM, et al. Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis. Cancer Discov. 2020;10(2):254–269. doi:10.1158/2159-8290.Cd-19-0672
   PubMed Web of Science ®Google Scholar
• Wu MJ, Wang Y, Yang D, et al. A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma. Ebiomedicine. 2019;41:244–255. doi:10.1016/j.ebiom.2019.02.012
   PubMed Web of Science ®Google Scholar
• He Y, Sun MM, Zhang GG, et al. Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425. doi:10.1038/s41392-021-00828-5
   PubMed Web of Science ®Google Scholar
• Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93–115. doi:10.1038/nrc.2016.138
   PubMed Web of Science ®Google Scholar
• Shi RS, Li M, Raghavan V, et al. Targeting the CDK4/6-Rb pathway enhances response to PI3K inhibition in PIK3CA-mutant lung squamous cell carcinoma. Clin Cancer Res. 2018;24(23):5990–6000. doi:10.1158/1078-0432.Ccr-18-0717
   PubMed Web of Science ®Google Scholar
• Yang QC, Ma XB, Xiao Y, et al. Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity. Acta Pharm Sin B. 2022;12(7):3139–3155. doi:10.1016/j.apsb.2022.02.024
   PubMed Web of Science ®Google Scholar
• Zhang MJ, Liang MY, Yang SC, et al. Bioengineering of BRAF and COX2 inhibitor nanogels to boost the immunotherapy of melanoma via pyroptosis. Chem Commun. 2023;59(7):932–935. doi:10.1039/d2cc05498a
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer. 2018;18(10):601–618. doi:10.1038/s41568-018-0037-0
   PubMed Web of Science ®Google Scholar
• Vultaggio-Poma V, Sarti AC, Di Virgilio F. Extracellular ATP: a feasible target for cancer therapy. Cells-Basel. 2020;9(11):2496. doi:10.3390/cells9112496
   PubMed Web of Science ®Google Scholar
• Allard B, Longhi MS, Robson SC, Stagg J. The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets. Immunol Rev. 2017;276(1):121–144. doi:10.1111/imr.12528
   PubMed Web of Science ®Google Scholar
• Wu L, Xie W, Li Y, et al. Biomimetic nanocarriers guide extracellular ATP homeostasis to remodel energy metabolism for activating innate and adaptive immunity system. Adv Sci. 2022;9(17):2105376. doi:10.1002/advs.202105376
   Web of Science ®Google Scholar
• Xiong HG, Ma XB, Wang XL, et al. Inspired epigenetic modulation synergy with adenosine inhibition elicits pyroptosis and potentiates cancer immunotherapy. Adv Funct Mater. 2021;31(20):2100007. doi:10.1002/adfm.202100007
   Web of Science ®Google Scholar
• Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nat Biomed Eng. 2021;5(9):951–967. doi:10.1038/s41551-021-00698-w
   PubMed Web of Science ®Google Scholar
• Qin XF, Yu CM, Wei J, et al. Rational design of nanocarriers for intracellular protein delivery. Adv Mater. 2019;31(46):1902791. doi:10.1002/adma.201902791
   Web of Science ®Google Scholar
• Mendes BB, Conniot J, Avital A, et al. Nanodelivery of nucleic acids. Nat Rev Meth Primers. 2022;2(1):24. doi:10.1038/s43586-022-00104-y
   PubMedGoogle Scholar
• Wang QY, Wang YP, Ding JJ, et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature. 2020;579(7799):421–426. doi:10.1038/s41586-020-2079-1
   PubMed Web of Science ®Google Scholar
• Ruhl S, Shkarina K, Demarco B, Heilig R, Santos JC, Broz P. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation. Science. 2018;362(6417):956–960. doi:10.1126/science.aar7607
   PubMed Web of Science ®Google Scholar
• Li ZT, Mo FY, Wang YX, et al. Enhancing gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response. Nat Commun. 2022;13(1):6321. doi:10.1038/s41467-022-34036-8
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang HB, Gu JM, et al. Engineered extracellular vesicles for cancer therapy. Adv Mater. 2021;33(14):2005709. doi:10.1002/adma.202005709
   PubMed Web of Science ®Google Scholar
• Xing YQ, Zhang FY, Ji PP, et al. Efficient delivery of GSDMD-N mRNA by engineered extracellular vesicles induces pyroptosis for enhanced immunotherapy. Small. 2023;19(20):e2204031. doi:10.1002/smll.202204031
   PubMed Web of Science ®Google Scholar
• Wang N, Liu C, Li Y, et al. A cooperative nano- CRISPR scaffold potentiates immunotherapy via activation of tumour-intrinsic pyroptosis. Nat Commun. 2023;14(1):779. doi:10.1038/s41467-023-36550-9
   PubMed Web of Science ®Google Scholar
• de Souza JG, Starobinas N, Ibanez OCM. Unknown/enigmatic functions of extracellular ASC. Immunology. 2021;163(4):377–388. doi:10.1111/imm.13375
   PubMed Web of Science ®Google Scholar
• Liu YX, Guo K, Ding M, et al. Engineered magnetic polymer nanoparticles can ameliorate breast cancer treatment inducing pyroptosis-starvation along with chemotherapy. ACS Appl Mater Interfaces. 2022;14(37):42541–42557. doi:10.1021/acsami.2c13011
   PubMed Web of Science ®Google Scholar
• Xia XJ, Wang X, Zheng Y, Jiang JQ, Hu JH. What role does pyroptosis play in microbial infection? J Cell Physiol. 2019;234(6):7885–7892. doi:10.1002/jcp.27909
   PubMed Web of Science ®Google Scholar
• Huang XH, Pan JM, Xu FN, et al. Bacteria-based cancer immunotherapy. Adv Sci. 2021;8(7):2003572. doi:10.1002/advs.202003572
   Web of Science ®Google Scholar
• Li ZT, Wang YX, Liu J, et al. Chemically and biologically engineered bacteria-based delivery systems for emerging diagnosis and advanced therapy. Adv Mater. 2021;33(38):2102580. doi:10.1002/adma.202102580
   PubMed Web of Science ®Google Scholar
• Howell LM, Forbes NS. Bacteria-based immune therapies for cancer treatment. Semin Cancer Biol. 2022;86:1163–1178. doi:10.1016/j.semcancer.2021.09.006
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu YP, Ning B, et al. Intravenous delivery of living listeria monocytogenes elicits gasdmermin-dependent tumor pyroptosis and motivates anti-tumor immune response. ACS Nano. 2022;16(3):4102–4115. doi:10.1021/acsnano.1c09818
   PubMed Web of Science ®Google Scholar
• Dhital S, Deo P, Stuart I, Naderer T. Bacterial outer membrane vesicles and host cell death signaling. Trends Microbiol. 2021;29(12):1106–1116. doi:10.1016/j.tim.2021.04.003
   PubMed Web of Science ®Google Scholar
• Wang SM, Guo JY, Bai Y, et al. Bacterial outer membrane vesicles as a candidate tumor vaccine platform. Front Immunol. 2022;13:987419. doi:10.3389/fimmu.2022.987419
   PubMed Web of Science ®Google Scholar
• Li YJ, Wu JY, Qiu XH, et al. Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy. Bioact Mater. 2023;20:548–560. doi:10.1016/j.bioactmat.2022.05.037
   PubMed Web of Science ®Google Scholar
• Chen LL, Ma X, Liu WJ, Hu QQ, Yang HH. Targeting pyroptosis through lipopolysaccharide-triggered noncanonical pathway for safe and efficient cancer immunotherapy. Nano Lett. 2023;23(18):8725–8733. doi:10.1021/acs.nanolett.3c02728
   PubMed Web of Science ®Google Scholar
• Deng WY, Bai Y, Deng F, et al. Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis. Nature. 2022;602(7897):496–502. doi:10.1038/s41586-021-04384-4
   PubMed Web of Science ®Google Scholar
• Sala R, Rioja-Blanco E, Serna N, et al. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases. Drug Deliv. 2022;29(1):1384–1397. doi:10.1080/10717544.2022.2069302
   PubMed Web of Science ®Google Scholar
• Rioja-Blanco E, Arroyo-Solera I, Alamo P, et al. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2022;41(1):49. doi:10.1186/s13046-022-02267-8
   PubMed Web of Science ®Google Scholar
• Zhao Z, Huang YB, Wang J, et al. A self-assembling CXCR4-targeted pyroptosis nanotoxin for melanoma therapy. Biomater Sci UK. 2023;11(6):2200–2210. doi:10.1039/d2bm02026b
   PubMed Web of Science ®Google Scholar
• Rahman MM, McFadden G. Oncolytic viruses: newest frontier for cancer immunotherapy. Cancers (Basel). 2021;13(21):5452. doi:10.3390/cancers13215452
   PubMed Web of Science ®Google Scholar
• Su W, Qiu W, Li SJ, et al. A dual-responsive STAT3 inhibitor nanoprodrug combined with oncolytic virus elicits synergistic antitumor immune responses by igniting pyroptosis. Adv Mater. 2023;35(11):e2209379. doi:10.1002/adma.202209379
   PubMed Web of Science ®Google Scholar
• Gao WT, Wang XY, Zhou Y, Wang XQ, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196. doi:10.1038/s41392-022-01046-3
   PubMed Web of Science ®Google Scholar
• Zhou RB, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140. doi:10.1038/ni.1831
   PubMed Web of Science ®Google Scholar
• Wu XX, Zhang HY, Qi W, et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis. 2018;9:171. doi:10.1038/s41419-017-0257-3
   PubMed Web of Science ®Google Scholar
• Chen MQ, Hu CY, Yang L, Guo QX, Liang YL, Wang WJ. Saikosaponin-D induces the pyroptosis of lung cancer by increasing ROS and activating the NF-κB/NLRP3/caspase-1/GSDMD pathway. J Biochem Mol Toxicol. 2023;37(8):e23444. doi:10.1002/jbt.23444
   PubMed Web of Science ®Google Scholar
• Teng JF, Mei QB, Zhou XG, et al. Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer. Cancers (Basel). 2020;12(1):193. doi:10.3390/cancers12010193
   PubMed Web of Science ®Google Scholar
• Zhou JZ, Zeng L, Zhang YW, et al. Cadmium exposure induces pyroptosis in testicular tissue by increasing oxidative stress and activating the AIM2 inflammasome pathway. Sci Total Environ. 2022;847:157500. doi:10.1016/j.scitotenv.2022.157500
   PubMed Web of Science ®Google Scholar
• An H, Heo JS, Kim P, et al. Tetraarsenic hexoxide enhances generation of mitochondrial ROS to promote pyroptosis by inducing the activation of caspase-3/GSDME in triple-negative breast cancer cells. Cell Death Dis. 2021;12(2):159. doi:10.1038/s41419-021-03454-9
   PubMed Web of Science ®Google Scholar
• Zhang XW, Zhang P, An L, et al. Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis. Acta Pharm Sin B. 2020;10(8):1397–1413. doi:10.1016/j.apsb.2020.06.015
   PubMed Web of Science ®Google Scholar
• Yang C, Wang ZQ, Zhang ZC, Lou G, Jin WL. CBL0137 activates ROS/BAX signaling to promote caspase-3/GSDME-dependent pyroptosis in ovarian cancer cells. Biomed Pharmacother. 2023;161:114529. doi:10.1016/j.biopha.2023.114529
   PubMed Web of Science ®Google Scholar
• Liu ZR, Li YQ, Zhu YL, et al. Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway. Int J Biol Sci. 2022;18(2):717–730. doi:10.7150/ijbs.64350
   PubMed Web of Science ®Google Scholar
• Zhang JY, Zhou B, Sun RY, et al. The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8. Cell Res. 2021;31(9):980–997. doi:10.1038/s41422-021-00506-9
   PubMed Web of Science ®Google Scholar
• Ding Y, Ye BL, Sun ZQ, Mao ZW, Wang WL. Reactive oxygen species-mediated pyroptosis with the help of nanotechnology: prospects for cancer therapy. Adv Nanobiomed Res. 2022;3(1):2200077. doi:10.1002/anbr.202200077
   Google Scholar
• Wu M, Liu XG, Chen H, et al. Activation of pyroptosis by membrane-anchoring AIE photosensitizer design: new prospect for photodynamic cancer cell ablation. Angew Chem Int Ed. 2021;60:9093–9098. doi:10.1002/anie.202016399
   PubMed Web of Science ®Google Scholar
• Li L, Tian HL, Zhang Z, et al. Carrier-free nanoplatform via evoking pyroptosis and immune response against breast cancer. ACS Appl Mater Interfaces. 2022;15(1):452–468. doi:10.1021/acsami.2c17579
   PubMed Web of Science ®Google Scholar
• Ma XB, Su W, Ye MJ, et al. Endogenous/exogenous stimulies inspired polyprodrug nano-inducer switches pyroptosis path for promoting antitumor immunity. Nano Today. 2023;48:101727. doi:10.1016/j.nantod.2022.101727
   Web of Science ®Google Scholar
• Qiu W, Su W, Xu JM, et al. Immunomodulatory-photodynamic nanostimulators for invoking pyroptosis to augment tumor immunotherapy. Adv Healthc Mater. 2022;11(21):2201233. doi:10.1002/adhm.202201233
   Web of Science ®Google Scholar
• Zhou JJ, Ma XB, Li H, et al. Inspired heat shock protein alleviating prodrug enforces immunogenic photodynamic therapy by eliciting pyroptosis. Nano Res. 2022;15(4):3398–3408. doi:10.1007/s12274-021-3946-2
   Web of Science ®Google Scholar
• Singleton DC, Macann A, Wilson WR. Therapeutic targeting of the hypoxic tumour microenvironment. Nat Rev Clin Oncol. 2021;18(12):751–772. doi:10.1038/s41571-021-00539-4
   PubMed Web of Science ®Google Scholar
• Wan YL, Fu LH, Li CY, Lin J, Huang P. Conquering the hypoxia limitation for photodynamic therapy. Adv Mater. 2021;33(48):2103978. doi:10.1002/adma.202103978
   PubMed Web of Science ®Google Scholar
• Su XX, Wang WJ, Cao Q, et al. A carbonic anhydrase IX (CAIX)-anchored Rhenium(I) photosensitizer evokes pyroptosis for enhanced anti-tumor immunity. Angew Chem Int Ed. 2022;61(8):e202115800. doi:10.1002/anie.202115800
   PubMed Web of Science ®Google Scholar
• Zhou JY, Wang WJ, Zhang CY, et al. Ru(II)-modified TiO2 nanoparticles for hypoxia-adaptive photo-immunotherapy of oral squamous cell carcinoma. Biomaterials. 2022;289:121757. doi:10.1016/j.biomaterials.2022.121757
   PubMed Web of Science ®Google Scholar
• Zhen WY, An SJ, Wang SQ, et al. Precise subcellular organelle targeting for boosting endogenous-stimuli-mediated tumor therapy. Adv Mater. 2021;33(51):2101572. doi:10.1002/adma.202101572
   Web of Science ®Google Scholar
• Zeng S, Chen C, Zhang LW, et al. Activation of pyroptosis by specific organelle-targeting photodynamic therapy to amplify immunogenic cell death for anti-tumor immunotherapy. Bioact Mater. 2023;25:580–593. doi:10.1016/j.bioactmat.2022.07.016
   PubMed Web of Science ®Google Scholar
• Chen BL, Yan Y, Yang Y, et al. A pyroptosis nanotuner for cancer therapy. Nat Nanotechnol. 2022;17(7):788–798. doi:10.1038/s41565-022-01125-0
   PubMed Web of Science ®Google Scholar
• Tang ZM, Liu YY, He MY, Bu WB. Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton-like reactions. Angew Chem Int Ed. 2019;58(4):946–956. doi:10.1002/anie.201805664
   PubMed Web of Science ®Google Scholar
• Tian QW, Xue FF, Wang YR, et al. Recent advances in enhanced chemodynamic therapy strategies. Nano Today. 2021;39:101162. doi:10.1016/j.nantod.2021.101162
   Web of Science ®Google Scholar
• Nadeem S, Yang C, Du Y, et al. A virus-spike tumor-activatable pyroptotic agent. Small. 2021;17(8):2006599. doi:10.1002/smll.202006599
   Web of Science ®Google Scholar
• Wang LY, Lu D, Huo MF, Xu HX. Oligomycin A induces apoptosis-to-pyroptosis switch against melanoma with sensitized immunotherapy. Adv Funct Mater. 2022;32(4):2106332. doi:10.1002/adfm.202106332
   Web of Science ®Google Scholar
• Deng HZ, Zhang J, Yang YF, et al. Chemodynamic and photothermal combination therapy based on dual-modified metal-organic framework for inducing tumor ferroptosis/pyroptosis. ACS Appl Mater Interfaces. 2022;14(21):24089–24101. doi:10.1021/acsami.2c00574
   PubMed Web of Science ®Google Scholar
• Xu SX, Zhou SY, Xie LYJ, et al. A versatile NiS2/FeS2 hybrid nanocrystal for synergistic cancer therapy by inducing ferroptosis and pyroptosis. Chem Eng J. 2023;460:141639. doi:10.1016/j.cej.2023.141639
   Web of Science ®Google Scholar
• Liang S, Yao JJ, Liu D, Rao L, Chen XY, Wang ZH. Harnessing nanomaterials for cancer sonodynamic immunotherapy. Adv Mater. 2023;35(33):e2211130. doi:10.1002/adma.202211130
   PubMed Web of Science ®Google Scholar
• Yang YR, Huang J, Liu M, et al. Emerging sonodynamic therapy-based nanomedicines for cancer immunotherapy. Adv Sci. 2023;10(2):2204365. doi:10.1002/advs.202204365
   Web of Science ®Google Scholar
• Yu Z, Cao WL, Han CY, et al. Biomimetic metal-organic framework nanoparticles for synergistic combining of SDT-chemotherapy induce pyroptosis in gastric cancer. Front Bioeng Biotechnol. 2022;10:796820. doi:10.3389/fbioe.2022.796820
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu W, Yang Z, et al. Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy. Theranostics. 2023;13(5):1571–1583. doi:10.7150/thno.79945
   PubMed Web of Science ®Google Scholar
• Yu SJ, Chen ZW, Zeng X, Chen XS, Gu Z. Advances in nanomedicine for cancer starvation therapy. Theranostics. 2019;9(26):8026–8047. doi:10.7150/thno.38261
   PubMed Web of Science ®Google Scholar
• Fu LH, Qi C, Hu YR, Lin J, Huang P. Glucose oxidase-instructed multimodal synergistic cancer therapy. Adv Mater. 2019;31(21):1808325. doi:10.1002/adma.201808325
   PubMed Web of Science ®Google Scholar
• Chang MQ, Wang ZY, Dong CH, et al. Ultrasound-amplified enzyodynamic tumor therapy by perovskite nanoenzyme-enabled cell pyroptosis and cascade catalysis. Adv Mater. 2023;35(7):e2208817. doi:10.1002/adma.202208817
   PubMed Web of Science ®Google Scholar
• Li JJ, Anraku Y, Kataoka K. Self-boosting catalytic nanoreactors integrated with triggerable crosslinking membrane networks for initiation of immunogenic cell death by pyroptosis. Angew Chem Int Ed. 2020;59(32):13526–13530. doi:10.1002/anie.202004180
   PubMed Web of Science ®Google Scholar
• Zhang SJ, Zhang Y, Feng YJ, et al. Biomineralized two-enzyme nanoparticles regulate tumor glycometabolism inducing tumor cell pyroptosis and robust antitumor immunotherapy. Adv Mater. 2022;34(50):e2206851. doi:10.1002/adma.202206851
   PubMed Web of Science ®Google Scholar
• Ding BB, Zheng P, Tan J, et al. Pyroptosis adjuvants: gram-scale production, cascade catalysis, and in situ antitumor immunity activation. Chem Mater. 2022;34(4):1800–1808. doi:10.1021/acs.chemmater.1c04048
   Web of Science ®Google Scholar
• Cai Z, Li CF, Han F, et al. Phosphorylation of PDHA by AMPK drives TCA cycle to promote cancer metastasis. Mol Cell. 2020;80(2):263–278. doi:10.1016/j.molcel.2020.09.018
   PubMed Web of Science ®Google Scholar
• Xie DB, Xu YT, Zhang YM, Cai WP, Lan X, Yan H. Pyruvate dehydrogenase kinase 1-dependent metabolic reprogramming: a promising target for postmenopausal osteoporosis treatment. Biomed Pharmacother. 2023;160:114411. doi:10.1016/j.biopha.2023.114411
   Web of Science ®Google Scholar
• Jin JK, Yuan PC, Yu W, et al. Mitochondria-targeting polymer micelle of dichloroacetate induced pyroptosis to enhance osteosarcoma immunotherapy. ACS Nano. 2022;16(7):10327–10340. doi:10.1021/acsnano.2c00192
   PubMedGoogle Scholar
• Kolb D, Kolishetti N, Surnar B, et al. Metabolic modulation of the tumor microenvironment leads to multiple checkpoint inhibition and immune cell infiltration. ACS Nano. 2020;14(9):11055–11066. doi:10.1021/acsnano.9b10037
   PubMed Web of Science ®Google Scholar
• Wang KW, Xiao X, Jiang ML, Li JS, Zhou JL, Yuan YY. An NIR-fluorophore-based theranostic for selective initiation of tumor pyroptosis-induced immunotherapy. Small. 2021;17(36):2102610. doi:10.1002/smll.202102610
   Web of Science ®Google Scholar
• Zheng P, Ding BB, Zhu GQ, Wang M, Li CX, Lin J. Biodegradable hydrogen peroxide nanogenerator for controllable cancer immunotherapy via modulating cell death pathway from apoptosis to pyroptosis. Chem Eng J. 2022;450:137967. doi:10.1016/j.cej.2022.137967
   Web of Science ®Google Scholar
• Zhen WY, Liu Y, An SJ, Jiang XE. Glutathione-induced in situ Michael addition between nanoparticles for pyroptosis and immunotherapy. Angew Chem Int Ed. 2023;62(20):e202301866. doi:10.1002/anie.202301866
   PubMed Web of Science ®Google Scholar
• Lee D, Ha J, Kang M, Yang ZG, Jiang W, Kim BYS. Strategies of perturbing ion homeostasis for cancer therapy. Adv Ther. 2022;5(2):2100189. doi:10.1002/adtp.202100189
   Google Scholar
• Chi YJ, Sun P, Gao Y, Zhang J, Wang LY. Ion interference therapy of tumors based on inorganic nanoparticles. Biosensors-Basel. 2022;12(2):100. doi:10.3390/bios12020100
   Web of Science ®Google Scholar
• Liu YY, Zhang M, Bu WB. Bioactive nanomaterials for ion-interference therapy. View. 2020;1(2):e18. doi:10.1002/viw2.18
   Google Scholar
• Ko SK, Kim SK, Share A, et al. Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells. Nat Chem. 2014;6(10):885–892. doi:10.1038/nchem.2021
   PubMed Web of Science ®Google Scholar
• Jiang W, Yin L, Chen HM, et al. NaCl nanoparticles as a cancer therapeutic. Adv Mater. 2019;31(46):e1904058. doi:10.1002/adma.201904058
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhen WY, Wang YH, Song SY, Zhang HJ. Na2S2O8 nanoparticles trigger antitumor immunotherapy through reactive oxygen species storm and surge of tumor osmolarity. J Am Chem Soc. 2020;142(52):21751–21757. doi:10.1021/jacs.0c09482
   PubMed Web of Science ®Google Scholar
• Saxena M, van der Burg SH, Melief CJM, Bhardwaj N. Therapeutic cancer vaccines. Nat Rev Cancer. 2021;21(6):360–378. doi:10.1038/s41568-021-00346-0
   PubMed Web of Science ®Google Scholar
• Tang J, Yang Y, Qu JJ, et al. Mesoporous sodium four-coordinate aluminosilicate nanoparticles modulate dendritic cell pyroptosis and activate innate and adaptive immunity. Chem Sci. 2022;13(29):8507–8517. doi:10.1039/d1sc05319a
   PubMed Web of Science ®Google Scholar
• Eil R, Vodnala SK, Clever D, et al. Ionic immune suppression within the tumour microenvironment limits t cell effector function. Nature. 2016;537(7621):539–543. doi:10.1038/nature19364
   PubMed Web of Science ®Google Scholar
• Rivers-Auty J, Brough D. Potassium efflux fires the canon: potassium efflux as a common trigger for canonical and noncanonical NLRP3 pathways. Eur J Immunol. 2015;45(10):2758–2761. doi:10.1002/eji.201545958
   PubMed Web of Science ®Google Scholar
• Wu LS, Bai SM, Huang J, et al. Nigericin boosts anti-tumor immune response via inducing pyroptosis in triple-negative breast cancer. Cancers (Basel). 2023;15(12):3221. doi:10.3390/cancers15123221
   PubMed Web of Science ®Google Scholar
• Niu Q, Liu Y, Zheng Y, et al. Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics. Acta Pharm Sin B. 2022;12(12):4458–4471. doi:10.1016/j.apsb.2022.11.002
   PubMed Web of Science ®Google Scholar
• Wang C, Cheng L, Liu Z. Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics. 2013;3(5):317–330. doi:10.7150/thno.5284
   PubMed Web of Science ®Google Scholar
• Ding BB, Sheng JY, Zheng P, et al. Biodegradable upconversion nanoparticles induce pyroptosis for cancer immunotherapy. Nano Lett. 2021;21(19):8281–8289. doi:10.1021/acs.nanolett.1c02790
   PubMed Web of Science ®Google Scholar
• Zhang M, Song RX, Liu YY, et al. Calcium-overload-mediated tumor therapy by calcium peroxide nanoparticles. Chem. 2019;5(8):2171–2182. doi:10.1016/j.chempr.2019.06.003
   Web of Science ®Google Scholar
• Zheng P, Ding BB, Zhu GQ, Li CX, Lin J. Biodegradable Ca2+ nanomodulators activate pyroptosis through mitochondrial Ca2+ overload for cancer immunotherapy. Angew Chem Int Ed. 2022;61(36):e202204904. doi:10.1002/anie.202204904
   PubMed Web of Science ®Google Scholar
• Ma ZY, Zhang J, Zhang WY, et al. Intracellular Ca2+ cascade guided by NIR-II photothermal switch for specific tumor therapy. Iscience. 2020;23(5):101049. doi:10.1016/j.isci.2020.101049
   PubMed Web of Science ®Google Scholar
• Zhao PF, Wang M, Chen M, et al. Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy. Biomaterials. 2020;254:120142. doi:10.1016/j.biomaterials.2020.120142
   PubMed Web of Science ®Google Scholar
• Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28(7):2029–2044. doi:10.1038/s41418-021-00814-y
   PubMed Web of Science ®Google Scholar
• Huang H, Weng Y, Tian W, Lin X, Chen J, Luo L. Molecular mechanisms of pyroptosis and its role in anti-tumor immunity. Int J Biol Sci. 2023;19(13):4166–4180. doi:10.7150/ijbs.86855
   PubMed Web of Science ®Google Scholar
• Cao W, Chen GD, Wu LJ, et al. Ionizing radiation triggers the antitumor immunity by inducing gasdermin E-mediated pyroptosis in tumor cells. Int J Radiat Oncol Biol Phys. 2023;115(2):440–452. doi:10.1016/j.ijrobp.2022.07.1841
   PubMed Web of Science ®Google Scholar
• Zhang YH, Shi JH, Ma B, et al. Functionalization of polymers for intracellular protein delivery. Prog Polym Sci. 2023;146:101751. doi:10.1016/j.progpolymsci.2023.101751
   Web of Science ®Google Scholar
• Yu XY, Xing GZ, Sheng SP, et al. Neutrophil camouflaged stealth nanovehicle for photothermal-induced tumor immunotherapy by triggering pyroptosis. Adv Sci. 2023;10(5):e2207456. doi:10.1002/advs.202207456
   Google Scholar
• Wen M, Yu N, Wu SW, et al. On-demand assembly of polymeric nanoparticles for longer-blood-circulation and disassembly in tumor for boosting sonodynamic therapy. Bioact Mater. 2022;18:242–253. doi:10.1016/j.bioactmat.2022.03.009
   PubMed Web of Science ®Google Scholar
• Wen M, Yu N, Yi ZG, et al. On-demand phototoxicity inhibition of sensitizers and H2S-triggered in situ activation for precise therapy of colon cancer. Nano Today. 2023;50:101863. doi:10.1016/j.nantod.2023.101863
   Web of Science ®Google Scholar
• Ding JX, Chen JJ, Gao LQ, et al. Engineered nanomedicines with enhanced tumor penetration. Nano Today. 2019;29:100800. doi:10.1016/j.nantod.2019.100800
   Web of Science ®Google Scholar
• Zhou Q, Dong CY, Fan WF, et al. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: the current status and transcytosis strategy. Biomaterials. 2020;240:119902. doi:10.1016/j.biomaterials.2020.119902
   PubMed Web of Science ®Google Scholar
• Ploetz E, Zimpel A, Cauda V, et al. Metal-organic framework nanoparticles induce pyroptosis in cells controlled by the extracellular pH. Adv Mater. 2020;32(19):1907267. doi:10.1002/adma.201907267
   PubMed Web of Science ®Google Scholar
• Wang H, Gao ZY, Jiao D, et al. A microenvironment dual-responsive nano-drug equipped with PD-L1 blocking peptide triggers immunogenic pyroptosis for prostate cancer self-synergistic immunotherapy. Adv Funct Mater. 2023;33(16):2214499. doi:10.1002/adfm.202214499
   Web of Science ®Google Scholar
• Hage C, Hoves S, Strauss L, et al. Sorafenib induces pyroptosis in macrophages and triggers natural killer cell-mediated cytotoxicity against hepatocellular carcinoma. Hepatology. 2019;70(4):1280–1297. doi:10.1002/hep.30666
   PubMed Web of Science ®Google Scholar
• Kong Q, Xia SY, Pan XX, et al. Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. Sci Immunol. 2023;8(82):eadg3196. doi:10.1126/sciimmunol.adg3196
   PubMed Web of Science ®Google Scholar
• Zhong X, Zeng H, Zhou ZW, et al. Structural mechanisms for regulation of GSDMB pore-forming activity. Nature. 2023;616(7957):598–605. doi:10.1038/s41586-023-05872-5
   PubMed Web of Science ®Google Scholar
• Zhang C, Xu MK, Zeng ZL, et al. A polymeric extracellular matrix nanoremodeler for activatable cancer photo-immunotherapy. Angew Chem Int Ed. 2023;62(12):e202217339. doi:10.1002/anie.202217339
   PubMedGoogle Scholar
• Vignali PDA, DePeaux K, Watson MJ, et al. Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. Nat Immunol. 2023;24(2):267–279. doi:10.1038/s41590-022-01379-9
   PubMed Web of Science ®Google Scholar
• Pan Y, Liu L, Mou X, Cai Y. Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment. ACS Nano. 2023;17(21):20875–20924. doi:10.1021/acsnano.3c07763
   PubMed Web of Science ®Google Scholar
• Li AW, Sobral MC, Badrinath S, et al. A facile approach to enhance antigen response for personalized cancer vaccination. Nat Mater. 2018;17(6):528–534. doi:10.1038/s41563-018-0028-2
   PubMed Web of Science ®Google Scholar
• Li SX, Luo M, Wang ZH, et al. Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nat Biomed Eng. 2021;5(5):455–466. doi:10.1038/s41551-020-00675-9
   PubMed Web of Science ®Google Scholar
• Xu WG, Su YZ, Ma Y, et al. Immunologically effective poly(D-lactic acid) nanoparticle enhances anticancer immune response. Sci China Chem. 2023;66(4):1150–1160. doi:10.1007/s11426-022-1441-7
   Web of Science ®Google Scholar
• Su YZ, Xu WG, Wei Q, Ma Y, Ding JX, Chen XS. Chiral polypeptide nanoparticles as nanoadjuvants of nanovaccines for efficient cancer prevention and therapy. Sci Bull. 2023;68(3):284–294. doi:10.1016/j.scib.2023.01.024
   PubMed Web of Science ®Google Scholar
• Xu LG, Wang XX, Wang WW, et al. Enantiomer-dependent immunological response to chiral nanoparticles. Nature. 2022;601(7893):366–373. doi:10.1038/s41586-021-04243-2
   PubMed Web of Science ®Google Scholar
• Zhang PF, Xiao YF, Sun X, et al. Cancer nanomedicine toward clinical translation: obstacles, opportunities, and future prospects. Med. 2023;4(3):147–167. doi:10.1016/j.medj.2022.12.001
   PubMedGoogle Scholar
• Zhang XY, Luan JY, Chen W, et al. Mesoporous silica nanoparticles induced hepatotoxicity via NLRP3 inflammasome activation and caspase-1-dependent pyroptosis. Nanoscale. 2018;10(19):9141–9152. doi:10.1039/c8nr00554k
   PubMed Web of Science ®Google Scholar
• Lu YH, Xu SC, Chen HY, et al. CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation. Biomaterials. 2016;90:27–39. doi:10.1016/j.biomaterials.2016.03.003
   PubMed Web of Science ®Google Scholar
• Chen YY, Lee YH, Wang B, Chen RJ, Wang YJ. Skin damage induced by zinc oxide nanoparticles combined with UVB is mediated by activating cell pyroptosis via the NLRP3 inflammasome-autophagy-exosomal pathway. Part Fibre Toxicol. 2022;19(1):2. doi:10.1186/s12989-021-00443-w
   PubMed Web of Science ®Google Scholar
• Tan C, Wang J, Sun BG. Biopolymer-liposome hybrid systems for controlled delivery of bioactive compounds: recent advances. Biotechnol Adv. 2021;48:107727. doi:10.1016/j.biotechadv.2021.107727
   PubMed Web of Science ®Google Scholar
• Zhao DK, Liang J, Huang XY, Shen S, Wang J. Organoids technology for advancing the clinical translation of cancer nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15(5):e1892. doi:10.1002/wnan.1892
   PubMed Web of Science ®Google Scholar